Table 6.
Comparison of the urinary assessment scales and urodynamic test results in female PD patients before and after DBS treatment
| Female PD patients before DBS (n=60) | Female PD patients after DBS (n=60) | P-value | |
|---|---|---|---|
| AUA-SI | 19.8±2.3 | 15.3±3.1 | 0.035 |
| Symptom score during urination | 13.1±3.5 | 10.6±3.8 | 0.038 |
| Symptom score during bladder storage | 6.7±2.7 | 4.7±2.2 | 0.033 |
| OAB-SS | 7.2±2.9 | 4.1±3.2 | 0.004 |
| QOL | 4.9±0.5 | 3.4±0.7 | 0.024 |
| Qmax (mL/s) | 13.1±2.9 | 15.4±6.0 | 0.034 |
| First sensation of bladder filling (ml) | 99.2±41.5 | 104.3±60.1 | 0.068 |
| Maximum bladder capacity (mL) | 223.5±40.8 | 318.3±38.2 | 0.039 |
| Pdet Qmax (cmH2O) | 30.2±7.1 | 38.3±7.8 | 0.043 |
| Residual urine (mL) | 66.7±10.8 | 45.9±6.4 | 0.041 |
| Bladder compliance (ml/cmH2O) | 32.5±5.6 | 35.2±4.7 | 0.124 |
Abbreviations: DBS, deep brain stimulation; PD, Parkinson’s disease; AUA-SI, American Urological Society Symptom Index; OAB-SS, Overactive Bladder Symptom Score; QOL, quality of life; Qmax, maximum urinary flow rate; Pdet, detrusor pressure at peak flow.